Home NDC 0781-3421 CASPOFUNGIN ACETATE
Product NDC 0781-3421
11-digit product format 007813421
Labeler code 0781
Product ID 0781-3421_d70d52c0-6601-f632-e053-2995a90a9291
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CASPOFUNGIN ACETATE
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Sandoz Inc
Application ANDA200833
Marketing category ANDA
Marketing start 2018-09-04
Substance CASPOFUNGIN ACETATE
Active strength 5 mg/mL
Pharmacologic classes Echinocandin Antifungal [EPC], Lipopeptides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A200833-001 CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS 2018-06-28 A200833-002 CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS 2018-06-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP RS 2018-06-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A200833-001 CASPOFUNGIN ACETATE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A200833-002 CASPOFUNGIN ACETATE 70MG/VIAL POWDER / INTRAVENOUS AP 2018-06-28 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 80 observed states.
Additional Listing Data#
Finished product Yes
Brand name base CASPOFUNGIN ACETATE
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CASPOFUNGIN ACETATE 5 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination VUW370O5QE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 828539 Internal RxNorm lookup 828755 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0781-3421-01 CASPOFUNGIN ACETATE 10.8 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 10.8 6 0781-3421-94 CASPOFUNGIN ACETATE 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0781-3421 CASPOFUNGIN ACETATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANDOZ INC] 6 Current NDC, Legacy NDC, 2 package rows 20220211_722facc6-d4ea-4975-b83e-3ae63df69ed2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0781-3421-01 00781342101 10.8 mL in 1 VIAL, SINGLE-DOSE 10.8 ml Historical 0781-3421-94 00781342194 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3421-94) / 10.8 mL in 1 VIAL, SINGLE-DOSE (0781-3421-01) 2018-09-04 0000-00-00 No No Current